Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Maki Shindo"'
Autor:
Aya Nakaya, Hideo Yagi, Hitomi Kaneko, Satoru Kosugi, Toru Kida, Yoko Adachi, Hirohiko Shibayama, Takae Kohara, Yuri Kamitsuji, Shin-ichi Fuchida, Nobuhiko Uoshima, Eri Kawata, Hitoji Uchiyama, Yuji Shimura, Takayuki Takahashi, Fumiaki Urase, Kensuke Ohta, Tsuneyoshi Hamada, Kazue Miyamoto, Masayuki Kobayashi, Maki Shindo, Hirokazu Tanaka, Chihiro Shimazaki, Masayuki Hino, Junya Kuroda, Yuzuru Kanakura, Akifumi Takaoari-Kondo, Shosaku Nomura, Itaru Matsumura
Publikováno v:
Leukemia Research Reports, Vol 10, Iss , Pp 7-10 (2018)
We retrospectively analyzed twenty-six patients with primary plasma cell leukemia (pPCL) registered from May 2005 until April 2015 by the Kansai Myeloma Forum. Twenty patients received novel agents (bortezomib or lenalidomide), and their median survi
Externí odkaz:
https://doaj.org/article/60725e003e734cd185128c760bbe013a
Autor:
Toru Kida, Hitomi Kaneko, Toshimitsu Matsui, Miki Kiyota, Shin-ichi Fuchida, Shosaku Nomura, Takae Kohara, Kansai Myeloma Forum Investigators, Nobuhiko Uoshima, Ryoichi Takahashi, Yoko Adachi, Kazunori Imada, Kensuke Ohta, Satoru Kosugi, Hirokazu Tanaka, Mitsuhiro Matsuda, Masato Iida, Akifumi Takaori-Kondo, Junya Kanda, Hideo Yagi, Hitoji Uchiyama, Masayuki Hino, Hirohiko Shibayama, Yuji Shimura, Yuzuru Kanakura, Katsuya Wada, Junya Kuroda, Takahiro Karasuno, Aya Nakaya, Itaru Matsumura, Maki Shindo, Chihiro Shimazaki
Publikováno v:
International Journal of Hematology. 112:666-673
We retrospectively analyzed 51 patients with solitary plasmacytoma diagnosed from October 2002 to September 2018 from a cohort of 3575 patients with plasma cell dyscrasias registered in the Kansai Myeloma Forum. Twenty-seven patients had solitary bon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::09e23912ba2625709c582de2d7e570ac
https://doi.org/10.1007/s12185-020-02961-3
https://doi.org/10.1007/s12185-020-02961-3
Autor:
Mineo Kurokawa, Hiroshi Kawabata, Maki Shindo-Ueda, Shunya Arai, Tomoko Hata, Kensuke Usuki, Shigeru Chiba, Yasushi Miyazaki, Masaharu Nohgawa, Kei Shimbo, Akifumi Takaori-Kondo, Nobuyoshi Arima, Akira Matsuda, Kaoru Tohyama, Junya Kanda, Kinuko Mitani, Kayano Araseki, Takahiro Suzuki, Hidekazu Kayano, Takayuki Ishikawa
Publikováno v:
International Journal of Hematology. 110:533-542
Serum ferritin, a marker of systemic iron status, is considered a prognostic factor for patients with myelodysplastic syndromes (MDS), despite the lack of supporting evidence. We investigated the association between serum ferritin levels at diagnosis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bca3b18a84440a4db72baac2554278c6
https://doi.org/10.1007/s12185-019-02710-1
https://doi.org/10.1007/s12185-019-02710-1
Autor:
Satoru Kosugi, Maki Shindo, Jun Ishikawa, Masaru Shibano, Hitomi Kaneko, Junya Kuroda, Itaru Matsumura, Eri Kawata, Shin-ichi Fuchida, Hitoji Uchiyama, Akifumi Takaori-Kondo, Nobuhiko Uoshima, Junya Kanda, Hirokazu Tanaka, Chihiro Shimazaki, Kazunori Imada, Hideo Yagi, Kensuke Ohta, Shosaku Nomura, Eiji Nakatani, Teruhito Takakuwa, Kanakura Y, Hirohiko Shibayama, Yuji Shimura, Tomoki Ito, Takahiro Karasuno, Masayuki Hino, Yoshifumi Shimizu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c285f0d92dd4ee439c537c17c6630de2
https://doi.org/10.1002/hon.2863/v2/response1
https://doi.org/10.1002/hon.2863/v2/response1
Autor:
Aya, Nakaya, Hirokazu, Tanaka, Hideo, Yagi, Kensuke, Ohta, Hirohiko, Shibayama, Takae, Kohara, Junya, Kanda, Maki, Shindo, Yuji, Shimura, Satoru, Kosugi, Toru, Kida, Hitomi, Kaneko, Kazunori, Imada, Takahiro, Karasuno, Mitsuhiro, Matsuda, Masato, Iida, Yoko, Adachi, Shin-Ichi, Fuchida, Nobuhiko, Uoshima, Hitoji, Uchiyama, Ryoichi, Takahashi, Toshimitsu, Matsui, Katsuya, Wada, Miki, Kiyota, Chihiro, Shimazaki, Masayuki, Hino, Junya, Kuroda, Yuzuru, Kanakura, Akifumi, Takaori-Kondo, Shosaku, Nomura, Itaru, Matsumura
Publikováno v:
International journal of hematology. 112(5)
We retrospectively analyzed 51 patients with solitary plasmacytoma diagnosed from October 2002 to September 2018 from a cohort of 3575 patients with plasma cell dyscrasias registered in the Kansai Myeloma Forum. Twenty-seven patients had solitary bon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2793d558efc6aebd0595924f290f4f9d
https://pubmed.ncbi.nlm.nih.gov/32783165
https://pubmed.ncbi.nlm.nih.gov/32783165
Autor:
Masayuki Kobayashi, Junya Kuroda, Toru Kida, Yuri Kamitsuji, Shin-ichi Fuchida, Takayuki Takahashi, Yoko Adachi, Hitomi Kaneko, Satoru Kosugi, Kazue Miyamoto, Tsuneyoshi Hamada, Itaru Matsumura, Hirokazu Tanaka, Chihiro Shimazaki, Akifumi Takaoari-Kondo, Hitoji Uchiyama, Hirohiko Shibayama, Kensuke Ohta, Shosaku Nomura, Hideo Yagi, Aya Nakaya, Takae Kohara, Eri Kawata, Yuji Shimura, Yuzuru Kanakura, Masayuki Hino, Fumiaki Urase, Nobuhiko Uoshima, Kansai Myeloma Forum Investigators, Maki Shindo
Publikováno v:
Leukemia Research Reports, Vol 10, Iss, Pp 7-10 (2018)
Leukemia Research Reports
Leukemia Research Reports
Highlights • The prevalence of pPCL was 1.2%. • Treatment with novel agents and transplantation may yield a better prognosis. • Hypercalcemia at diagnosis was suggested to predict worse outcomes.
We retrospectively analyzed twenty-six pati
We retrospectively analyzed twenty-six pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ba0d9bbca03060060c40221780d0d62
http://www.sciencedirect.com/science/article/pii/S2213048918300438
http://www.sciencedirect.com/science/article/pii/S2213048918300438
Autor:
Maki Shindo, Wei Chen
Publikováno v:
The Journal of Immunology. 184:131.31-131.31
This study investigated whether tumor-specific T cells can be elicited by vaccination with tumor cell lysate plus CpG oligodeoxynucleotides (CpG/lysate) for adoptive immunotherapy. Vaccination of C57BL/6 mice with syngeneic EL-4 tumor cell lysate mix
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::265ad1142247c2e4093148d7bc373c22
https://doi.org/10.4049/jimmunol.184.supp.131.31
https://doi.org/10.4049/jimmunol.184.supp.131.31
Publikováno v:
Blood. 110:160-160
Acute myeloid leukemia (AML) is a common form of acute leukemia and remains a difficult disease with poor survival in patients who have failed standard therapy. New therapeutic strategies are needed to achieve longer survival and improve cure rates i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::18467e9e5898feead1bcf52a25d8dbc2
https://doi.org/10.1182/blood.v110.11.160.160
https://doi.org/10.1182/blood.v110.11.160.160
Autor:
Hirokazu Tanaka, Satoru Kosugi, Toru Kida, Kensuke Ohta, Ryosuke Yamamura, Hirohiko Shibayama, Takae Kohara, Hitomi Kaneko, Shin-ichi Fuchida, Masayuki Kobayashi, Kazue Miyamoto, Maki Shindo, Junya Kuroda, Nobuhiko Uoshima, Yayoi Matsumura, Yumi Yoshii, Yuri Kamitsuji, Shogen Boku, Kazuyoshi Ishii, Mitsuhiro Matsuda, Takayuki Takahashi, Tsuneyoshi Hamada, Yoko Adachi, Eiji Nakatani, Shosaku Nomura, Masafumi Taniwaki, Akifumi Takaori, Chihiro Shimazaki, Mitsuru Tsudo, Masayuki Hino, Itaru Matsumura, Yuzuru Kanakura
Publikováno v:
ResearcherID
Introduction There has been dramatic evolution in multiple myeloma (MM) therapy in the last decade. The novel agents (Thal, Bor, and Len) have been reported to improve natural history of the cases with MM. In order to use optimal drugs for each patie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a3792bddfb23cafef73dc032b841e69
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000331385007149&KeyUID=WOS:000331385007149
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000331385007149&KeyUID=WOS:000331385007149